software developers Nostos Genomics Aims to Ease Variant Interpretation Bottlenecks With AI Premium The German bioinformatics startup recently partnered with Genomics England and Genomenon as it seeks to accelerate and bring transparency to genetic testing processes. Engine Biosciences Using CRISPR, Machine Learning to Build Drug Candidate Pipeline Premium Fresh off a $43 million fundraising round, the drug discovery-focused bioinformatics firm is validating novel drug targets and compounds with an eye toward 2023 clinical trials. Genomenon, Nostos Genomics to Integrate Technologies to Improve Rare Disease Dx Genomenon will embed its Mastermind genomic search engine into the AI-driven Nostos AIon variant interpretation platform to power clinical decision support. Euformatics Expands Latin American Presence With A&C Group Distribution Deal The deal with A&C Group gives Euformatics a foothold in Bolivia, Peru, and Paraguay, building on an earlier partnership in Brazil. AccessDx, Jase Health Partnership Looks to Streamline Pharmacogenomics for Clinicians Premium EMR integrator Jase Health is embedding molecular diagnostics data from AccessDx Laboratories into clinical workflows for hospitals and LTC facilities. May 19, 2021 Meditech, FDB Integration Aims to Bring Genomic Clinical Decision Support to Point of Care Premium Apr 27, 2021 Seven Bridges Raises $15M in First Closing of Series C Apr 23, 2021 WANdisco Moves Into Genomics With Korean Data Deal Premium Apr 22, 2021 Seqster Closes $12M Series A Funding Round Apr 19, 2021 Korean Rare Disease Diagnostics Firm 3billion Looks to 2022 IPO, Expansion Into Drug Discovery Premium Apr 15, 2021 Trapelo Health, Magellan Hope to Ease Prior Authorization for Precision Oncology Testing Premium Apr 13, 2021 Congenica Strikes Asian Distribution Deal With Camtech Diagnostics Apr 12, 2021 Genomenon, Limbus Medical to Integrate Technologies for Clinical Variant Interpretation Apr 12, 2021 Sanford Health Looks to Improve Rare Disease Dx, Research With Congenica Technology Premium Apr 8, 2021 Trapelo Health, Magellan Rx Team on Value-Based Precision Oncology Apr 7, 2021 Qlucore Raises SEK 30M as it Looks Toward IPO Apr 6, 2021 Euformatics Eyes Global Expansion in NGS Informatics Premium Mar 31, 2021 Rosalind, Formerly OnRamp Bio, Pushes Into Single-Cell Analysis, SARS-CoV-2 Variant Monitoring Premium Mar 26, 2021 GranatumX Platform Gathers Single-Cell Analysis Tools for Researchers, Bioinformatics Developers Premium Mar 22, 2021 Insightful Science to Acquire Dotmatics Mar 19, 2021 Allelica Wants Polygenic Risk Scores to Become Routine in Heart Disease Care Premium Mar 18, 2021 Genialis Teams With Slovenian Bioinformatics Group to Develop Precision Medicine Tools Mar 17, 2021 Genomics Plc Looks to Grow 'Genomic Prevention' With Polygenic Risk Scores Premium Mar 11, 2021 Allelica Raises $1.75M Seed Round, Moves Headquarters to US Mar 2, 2021 Genomics Plc Closes $30M Funding Round Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.